角膜移植市场规模、份额、成长分析（按类型、适应症、最终用户、地区）- 2025-2032 年产业预测

2023 年角膜移植市场规模为 4.8999 亿美元，预计将从 2024 年的 5.2674 亿美元增长到 2032 年的 9.3943 亿美元，预测期内（2025-2032 年）的复合年增长率为 7.5%。

根据美国美国卫生研究院 (NIH) 的最新研究结果，10% 至 15% 的圆锥角膜患者在治疗过程中需要进行角膜移植。这凸显了角膜植入在有效治疗常见眼科疾病圆锥角膜方面的重要作用。此外，角膜失明是全球面临的重大健康挑战，在致盲原因中位列青光眼和白内障之后的第三位，影响全球约 1,000 万人。这些数据表明，医疗保健系统需要角膜植入的创新解决方案和进步的巨大市场机会，以满足大量患者的需求并在全球范围内对抗角膜失明的后果。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管分析
• 技术分析

角膜移植市场规模（按类型及复合年增长率）（2025-2032）

• 市场概览
• 全层角膜移植
• 内皮角膜移植手术
• Descemet 膜剥离自动内皮角膜移植 (DSAEK)
• 角膜移植
• 角膜缘干细胞移植
• 其他的

角膜移植市场规模（按适应症和复合年增长率）（2025-2032）

• 市场概览
• 真菌性角膜溃疡
• 水痘角膜病变
• 圆锥角膜
• 角膜炎
• 角膜基质营养不良
• 其他的

角膜移植市场规模（按最终用户和复合年增长率） （2025-2032）

• 市场概览
• 医院
• 眼科诊所
• 其他的

角膜移植市场规模：依地区及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• CorneaGen（USA）
• Eversight（USA）
• Lions VisionGift（USA）
• Keramed Inc.（USA）
• EyeYon Medical（Israel）
• Aurolab（India）
• Presbia PLC（Ireland）
• Mediphacos（Brazil）
• DIOPTEX GmbH（Austria）
• AJL Ophthalmic SA（Spain）
• Florida Lions Eye Bank（USA）
• Ocular Systems Inc.（USA）
• Gebauer Medizintechnik GmbH（Germany）
• Tomey Corporation（Japan）
• SightLife（USA）
• Ampleye（Netherlands）
• Allotex（USA）
• Eye Bank Association of America（EBAA）（USA）
• Boston Keratoprosthesis（Boston KPro）（USA）
• IOPtima Ltd.（Israel）

结论和建议

Corneal Transplant Market size was valued at USD 489.99 million in 2023 and is poised to grow from USD 526.74 million in 2024 to USD 939.43 million by 2032, growing at a CAGR of 7.5% during the forecast period (2025-2032).

Recent findings from the National Institutes of Health (NIH) indicate that 10-15% of keratoconus patients require corneal implant procedures during their treatment journey. This highlights the critical role of corneal implants in effectively managing keratoconus, a prevalent ocular condition. Additionally, corneal blindness poses a significant global health challenge, ranking as the third leading cause of blindness after glaucoma and cataracts, impacting an estimated 10 million individuals worldwide. The data reveals a vital market opportunity for innovative solutions and advancements in corneal implants, as healthcare systems seek to address the needs of this substantial patient population and combat the consequences of corneal blindness on a global scale.

Top-down and bottom-up approaches were used to estimate and validate the size of the Corneal Transplant market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Corneal Transplant Market Segments Analysis

Global Corneal Transplant Market is segmented by Type, Indications, End-User and region. Based on Type, the market is segmented into Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty (DSAEK), Corneal Graft, Corneal Limbal Stem Cell Transplant and Others. Based on Indications, the market is segmented into Fungal Corneal Ulcer, Bullous Keratopathy, Keratoconus, Keratitis, Corneal Stromal Dystrophies and Others. Based on End-User, the market is segmented into Hospital, Eye Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Corneal Transplant Market

One of the key market drivers for the global corneal transplant market is the rising prevalence of corneal diseases and conditions, such as keratoconus, corneal scarring, and endothelial dysfunction. As aging populations increase worldwide, the incidence of these eye disorders is also growing, leading to a higher demand for corneal transplantation procedures to restore vision and improve quality of life. Additionally, advancements in surgical techniques and technologies, such as femtosecond laser-assisted surgery and improved preservation methods for donor corneas, are enhancing the success rates of transplants, further propelling market growth as healthcare providers seek effective treatment options for patients.

Restraints in the Corneal Transplant Market

The growth of the corneal transplant market is hindered by several notable constraints, primarily the high costs associated with the procedure and a limited supply of donor corneas. The financial implications of corneal transplantation, which include expenses related to pre-operative evaluations, surgical procedures, and subsequent post-operative care, create a substantial economic burden for both patients and healthcare systems. These elevated costs can restrict access to treatment, especially in areas with limited healthcare resources, thereby impeding the overall expansion of the market. Additionally, the scarcity of available donor material further exacerbates these challenges, making it difficult for the market to flourish.

Market Trends of the Corneal Transplant Market

The corneal transplant market is witnessing remarkable growth driven by technological advancements and an increasing geriatric population. Innovative corneal implants are enhancing the treatment's efficacy for eye disorders, particularly as conditions like Fuchs' dystrophy become more prevalent among individuals over 40. The aging demographic underscores a rising need for effective solutions to age-related eye diseases, propelling market demand. Additionally, greater awareness of corneal health and improved surgical techniques further bolster this trend. As such, the corneal transplant market is positioned for continued expansion, characterized by a surge in transplantation procedures and the development of next-generation implants.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Technology Analysis

Global Corneal Transplant Market Size by Type & CAGR (2025-2032)

• Market Overview
• Penetrating Keratoplasty
• Endothelial Keratoplasty
• Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)
• Corneal Graft
• Corneal Limbal Stem Cell Transplant
• Others

Global Corneal Transplant Market Size by Indications & CAGR (2025-2032)

• Market Overview
• Fungal Corneal Ulcer
• Bullous Keratopathy
• Keratoconus
• Keratitis
• Corneal Stromal Dystrophies
• Others

Global Corneal Transplant Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Hospital
• Eye Clinics
• Others

Global Corneal Transplant Market Size & CAGR (2025-2032)

• North America (Type, Indications, End-User)
  • US
  • Canada
• Europe (Type, Indications, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Indications, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Indications, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Indications, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• CorneaGen (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eversight (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lions VisionGift (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Keramed Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EyeYon Medical (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aurolab (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Presbia PLC (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mediphacos (Brazil)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DIOPTEX GmbH (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AJL Ophthalmic S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Florida Lions Eye Bank (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ocular Systems Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gebauer Medizintechnik GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tomey Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SightLife (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ampleye (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allotex (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eye Bank Association of America (EBAA) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Keratoprosthesis (Boston KPro) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IOPtima Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations